SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0001005201-19-000018
Filing Date
2019-02-14
Accepted
2019-02-14 16:18:33
Documents
2
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 5 wf-form5_155017910009665.html 5  
1 FORM 5 wf-form5_155017910009665.xml 5 5966
2 LAVIGNE POA ex-24.htm EX-24 3123
  Complete submission text file 0001005201-19-000018.txt   10578
Mailing Address 100 SOUTH SAUNDERS RD SUITE 300 LAKE FOREST IL 60045
Business Address 100 SOUTH SAUNDERS RD SUITE 300 LAKE FOREST IL 60045 (224) 419-7106
Assertio Therapeutics, Inc (Issuer) CIK: 0001005201 (see all company filings)

IRS No.: 943229046 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ALLERGAN, INC. 2525 DUPONT DRIVE IRVINE CA 92612
Business Address
LAVIGNE LOUIS J JR (Reporting) CIK: 0001214127 (see all company filings)

Type: 5 | Act: 34 | File No.: 001-13111 | Film No.: 19606620